Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop...

Bright Minds Biosciences Shares to Commence Trading on the OTCQB Venture...

Algernon Pharmaceuticals Receives Positive Feedback from U.S. FDA for Psychedelic Drug...

PharmaTher Announces FDA Approval of Ketamine IND In The Treatment of...

MindMed Receives FDA Type C Meeting Response for Project Lucy Phase...

BetterLife Announces Closing of a Non-Brokered Private Placement

Entheon Biomedical Corp. Provides Corporate Update

MindMed Announces 2021 Q1 Financial Results; Cash Balance of $160m USD...

Psychedelic Bulletin: MAPS Study Published in Nature Medicine; Numinus’ Hiring Spree;...

PTSF59 – Bipolar and Psychedelics, with Benjamin Mudge

Load more